CatchMe Theraputics

Precision Medicine for Epitranscriptome Machinery

Health Tech & Life Sciences
Active
Pre-Seed Ness Ziona, Israel Founded 2021
LinkedIn
Last updated 2026-06-18
Total raised
—
Last: 2021-12
Stage
Pre-Seed
Founded
2021
Headcount
6
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences

About

CatchMe Therapeutics develops a solution for specific inhibition based on the in vivo biological binding preference of targeted proteins. The company's versatile platform can be expanded to target different methyl binding proteins and different indications.

Funding history · 1 round · — total

2021-12
Undisclosed
FutuRx

Q&A

What is CatchMe Theraputics' primary focus?
CatchMe Theraputics focuses on precision medicine for epitranscriptome machinery, developing solutions for specific inhibition based on the in vivo biological binding preference of targeted proteins.
When was CatchMe Theraputics founded?
CatchMe Theraputics was founded in August 2021.
Where is CatchMe Theraputics headquartered?
CatchMe Theraputics is headquartered in Ness Ziona, Israel.
How many employees does CatchMe Theraputics have?
CatchMe Theraputics has 1-10 employees.
What is CatchMe Theraputics' current funding stage?
CatchMe Theraputics is currently in the Pre-Seed funding stage.
Which investor participated in CatchMe Theraputics' December 2021 funding round?
FutuRx participated in CatchMe Theraputics' funding round in December 2021.
What sectors does CatchMe Theraputics operate in?
CatchMe Theraputics operates in the Health Tech & Life Sciences, Pharma & Medical Biotechnology, and Drugs Discovery & Development sectors.
What is the product stage of CatchMe Theraputics?
CatchMe Theraputics' product is currently in the R&D stage.

Team · 1

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesPatientsLife SciencesBiotechnologyPharmaceuticals
Business model
B2B

Tags

proteinsdrug-developmenthospitalspharmaceuticalscancer-therapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)